Form 4: Intuitive Surgical Director Jami Nachtsheim Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Director Jami Nachtsheim exercised stock options and sold shares of Intuitive Surgical (ISRG) under a pre-arranged 10b5-1 trading plan.

Summary

  • Jami Nachtsheim, a director at Intuitive Surgical, executed a transaction involving the company's stock on May 1, 2025.
  • Nachtsheim exercised non-qualified stock options to acquire 2,400 shares at a price of $90.4944 per share.
  • Simultaneously, Nachtsheim sold 2,400 shares at $520 per share.
  • These transactions were executed under a pre-arranged trading plan that complies with SEC Rule 10b5-1.
  • Following these transactions, Nachtsheim directly owns 6,371 shares of Intuitive Surgical common stock.
  • Nachtsheim also holds 2,235 non-qualified stock options and 531 restricted stock units (RSUs).

Sentiment

Score: 5

Explanation: Neutral sentiment as the document reports routine insider transactions under a pre-existing trading plan. No indication of positive or negative outlook.

Future Outlook

The director's future transactions may be governed by the existing 10b5-1 trading plan, which expires on December 10, 2025.

Industry Context

Insider transactions are common and closely monitored, especially in high-growth sectors like robotic surgery. The use of a 10b5-1 plan indicates a pre-arranged strategy to avoid accusations of trading on inside information.

Comparison to Industry Standards

  • Stock option grants and RSU awards are standard compensation practices for directors in publicly traded companies, particularly in the technology and healthcare sectors.
  • Companies like Medtronic, Stryker, and Johnson & Johnson also utilize similar equity-based compensation plans for their executives and directors.
  • The vesting schedules and terms of these equity awards are generally aligned with industry norms to incentivize long-term performance and retention.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders as they are part of a pre-arranged trading plan.
  • Shareholders may view insider sales with caution, but the 10b5-1 plan mitigates concerns about opportunistic trading.

Key Dates

DateDescription
05/01/2025Date of transaction: stock option exercise and sale of shares.
04/20/2027Expiration date of non-qualified stock options.
12/10/2025Expiration date of the 10b5-1 trading plan.

Keywords

Intuitive Surgical, ISRG, Form 4, Director, Stock Options, RSUs, 10b5-1 Trading Plan, Jami Nachtsheim, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.